Proctis-M (citicoline) rectal suppositories 2 g. №10

$30.30

Purpose: Citicoline supplements brain function via rectal administration for cognitive enhancement.

SKU: MED60739 Category:

Description

Proctis-M (citicoline) rectal suppositories 2 g. №10

Ingredients:

Each rectal suppository contains 2 g of citicoline.

Dosage:

The recommended dosage is one suppository inserted into the rectum once daily.

Indications:

Proctis-M is indicated for the treatment of cognitive disorders of various origins. It is commonly used in conditions such as head injury, stroke, and age-related memory impairment.

Contraindications:

Do not use Proctis-M if you are allergic to citicoline or any other ingredients in the suppository. Consult your healthcare provider before use if you are pregnant, nursing, or have any underlying medical conditions.

Directions:

For rectal use only. Insert one suppository into the rectum and retain it for as long as possible. Follow the instructions provided by your healthcare provider for the best results.

Scientific Evidence:

Citicoline, the active ingredient in Proctis-M, has been extensively studied for its neuroprotective and cognitive-enhancing properties. Research published in the Journal of Neural Transmission suggests that citicoline supplementation may improve cognitive function and memory in individuals with cognitive impairment.

Additional Information:

It is important to store Proctis-M at room temperature away from moisture and heat. Keep out of reach of children. If you experience any adverse reactions, discontinue use and consult your healthcare provider.

Pharmacological Effects: Citicoline is thought to enhance the synthesis of phospholipids in the brain, which can improve neuronal function and communication. This mechanism of action makes it a promising agent in the treatment of cognitive disorders.

Clinical Trials: A randomized controlled trial published in the Journal of Alzheimer’s Disease showed that citicoline supplementation led to significant improvements in memory and cognitive function in elderly individuals with mild cognitive impairment. These findings support the use of Proctis-M in the management of cognitive disorders.